Tapewire

Nasdaq · USD

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3132
SEC CIK
0001178670
Parsed reports
483

Last 12 months

Inside the activity.

0 purchase rows · 279 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025031
Dec 202500
Jan 20260111
Feb 2026011
Mar 20260106
Apr 2026014
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 07, 2023 Filed Mar 9, 2023 21:12 UTC GrantStock Option (right to buy) · Derivative 4,948 $0.00 Strike: $194.34 $0.00
Disclosure

SEC source: 0001735276-23-000036 · edgardoc.xml · derivative · entry 1

KELLOGG PETER N · CIK 0001226287 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,948

Underlying: Common Stock · 4,948 shares

Expires 2033-03-07

F1 · derivative.exercise_date: The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:07 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $96.45 $0.00
Disclosure

SEC source: 0001735276-23-000033 · edgardoc.xml · derivative · entry 7

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2024-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

F4 · derivative.exercise_date: The stock option vested as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date, and were fully vested on December 17, 2018.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:07 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionPerformance Stock Option 2014 (right to buy) · Derivative 2,500 $0.00 Strike: $96.45 $0.00
Disclosure

SEC source: 0001735276-23-000033 · edgardoc.xml · derivative · entry 6

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2024-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:07 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
SaleCommon Stock 18,072 $200.00 $3,614,400.00
Disclosure

SEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 3

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,345

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:07 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionCommon Stock 2,500 $96.45 $241,125.00
Disclosure

SEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 2

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:07 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
Exercise / conversionCommon Stock 2,500 $96.45 $241,125.00
Disclosure

SEC source: 0001735276-23-000033 · edgardoc.xml · nonDerivative · entry 1

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:23 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 36,775 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000031 · edgardoc.xml · derivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,775

Underlying: Common Stock · 36,775 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:23 UTC
Greenstreet YvonneDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 17,763 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000031 · edgardoc.xml · derivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,763

Underlying: Common Stock · 17,763 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 35,525 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:22 UTC GrantStock Option (right to buy) · Derivative 11,986 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000030 · edgardoc.xml · derivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,986

Underlying: Common Stock · 11,986 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:22 UTC GrantRestricted Stock Units · Derivative 5,790 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000030 · edgardoc.xml · derivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,790

Underlying: Common Stock · 5,790 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,579 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:22 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
GrantStock Option (right to buy) · Derivative 11,850 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000029 · edgardoc.xml · derivative · entry 2

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,850

Underlying: Common Stock · 11,850 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:22 UTC
Garg PushkalCMO & EVP Dev & Med Affairs
GrantRestricted Stock Units · Derivative 5,724 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000029 · edgardoc.xml · derivative · entry 1

Garg Pushkal · CIK 0001829252 · CMO & EVP Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,724

Underlying: Common Stock · 5,724 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,447 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
GrantStock Option (right to buy) · Derivative 11,850 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000028 · edgardoc.xml · derivative · entry 2

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,850

Underlying: Common Stock · 11,850 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Poulton Jeffrey V.EVP, Chief Financial Officer
GrantRestricted Stock Units · Derivative 5,724 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000028 · edgardoc.xml · derivative · entry 1

Poulton Jeffrey V. · CIK 0001782962 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,724

Underlying: Common Stock · 5,724 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 11,447 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Tanguler TolgaEVP, Chief Commercial Officer
GrantStock Option (right to buy) · Derivative 10,352 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000027 · edgardoc.xml · derivative · entry 2

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,352

Underlying: Common Stock · 10,352 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Tanguler TolgaEVP, Chief Commercial Officer
GrantRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000027 · edgardoc.xml · derivative · entry 1

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 10,000 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Franchini Indrani LallEVP, CLO & Secretary
GrantStock Option (right to buy) · Derivative 5,449 $0.00 Strike: $190.01 $0.00
Disclosure

SEC source: 0001735276-23-000026 · edgardoc.xml · derivative · entry 2

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,449

Underlying: Common Stock · 5,449 shares

Expires 2033-02-27

F4 · shares: Represents the time-vested stock option portion of the reporting person's annual equity award granted in 2023 for 2022 performance.

F5 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the grant date and as to an additional 6.25% of the shares at the end of each successive three month period thereafter until the fourth anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:21 UTC
Franchini Indrani LallEVP, CLO & Secretary
GrantRestricted Stock Units · Derivative 2,632 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000026 · edgardoc.xml · derivative · entry 1

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,632

Underlying: Common Stock · 2,632 shares

Expires 2026-02-27

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · shares: Represents the time-vested restricted stock unit portion of the reporting person's annual equity award granted in 2023 for 2022 performance. The reporting person also received 5,263 performance stock units as part of their annual equity award that will vest upon the achievement of three specific performance conditions (subject to a one year minimum vesting period), which will be reported on a Form 4 as to the performance stock units allocated to each performance condition if and when each performance condition is met and the performance stock units vest.

F3 · derivative.exercise_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

F3 · derivative.expiration_date: The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:13 UTC Exercise / conversionRestricted Stock Units · Derivative 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000018 · edgardoc.xml · derivative · entry 3

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F3 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:13 UTC Exercise / conversionCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000018 · edgardoc.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:13 UTC Exercise / conversionRestricted Stock Units · Derivative 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000019 · edgardoc.xml · derivative · entry 2

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date.

F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:13 UTC Exercise / conversionCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000019 · edgardoc.xml · nonDerivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:12 UTC Exercise / conversionRestricted Stock Units · Derivative 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000017 · edgardoc.xml · derivative · entry 2

HAMBURG MARGARET A · CIK 0001266917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date.

F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:12 UTC Exercise / conversionCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000017 · edgardoc.xml · nonDerivative · entry 1

HAMBURG MARGARET A · CIK 0001266917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:11 UTC Exercise / conversionRestricted Stock Units · Derivative 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000016 · edgardoc.xml · derivative · entry 2

Fanucci Marsha · CIK 0001298814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date.

F2 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:11 UTC Exercise / conversionCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000016 · edgardoc.xml · nonDerivative · entry 1

Fanucci Marsha · CIK 0001298814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:11 UTC Exercise / conversionRestricted Stock Units · Derivative 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000015 · edgardoc.xml · derivative · entry 3

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F3 · derivative.exercise_date: This award vested on February 23, 2023, the first anniversary of the grant date.

F3 · derivative.expiration_date: This award vested on February 23, 2023, the first anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:11 UTC Exercise / conversionCommon Stock 136 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000015 · edgardoc.xml · nonDerivative · entry 1

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC Exercise / conversionStock Option (right to buy) · Derivative 30,913 $0.00 Strike: $63.00 $0.00
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · derivative · entry 8

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,913 shares

Expires 2023-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F8 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC SaleCommon Stock 4,302 $217.05 $933,749.10
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 6

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,970

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $216.96 to $217.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC SaleCommon Stock 19,447 $216.38 $4,207,941.86
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 5

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,272

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F5 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $215.89 to $216.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC SaleCommon Stock 10,279 $215.59 $2,216,049.61
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 4

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,719

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $214.88 to $215.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC SaleCommon Stock 2,307 $214.28 $494,343.96
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 3

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,998

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $213.72 to $214.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC SaleCommon Stock 1,709 $213.13 $364,239.17
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,305

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $212.71 to $213.70. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 21:03 UTC Exercise / conversionCommon Stock 30,913 $63.00 $1,947,519.00
Disclosure

SEC source: 0001735276-23-000009 · edgardoc.xml · nonDerivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.

Read SEC document
February 03, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 953 $233.31 $222,344.43
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 10

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.

F10 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $233.02 to $233.81. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 1,293 $232.53 $300,661.29
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 9

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 953

F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.

F9 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $231.94 to $232.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 865 $231.35 $200,117.75
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 8

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,246

F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.

F8 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $230.90 to $231.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 185 $230.20 $42,587.00
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 7

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,111

F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.

F7 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $229.87 to $230.62. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 03, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 128 $227.68 $29,143.04
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 6

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,296

F5 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.

F6 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $227.63 to $228.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 5 $227.38 $1,136.90
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 5

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 586 $226.62 $132,799.32
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 4

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,505

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 1,007 $225.80 $227,380.60
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 3

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,091

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
SaleCommon Stock 77 $223.97 $17,245.69
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 2

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,098

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 4 $227.38 $909.52
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 5

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,424

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 561 $226.62 $127,133.82
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 4

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,428

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F4 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 963 $225.80 $217,445.40
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 3

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,989

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F3 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 22:45 UTC
Tanguler TolgaEVP, Chief Commercial Officer
SaleCommon Stock 73 $223.97 $16,349.81
Disclosure

SEC source: 0001735276-23-000006 · edgardoc.xml · nonDerivative · entry 2

Tanguler Tolga · CIK 0001849458 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,952

F1 · kind: Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.

F2 · price: The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
Exercise / conversionRestricted Stock Units · Derivative 5,175 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · derivative · entry 6

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,350

Underlying: Common Stock · 5,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F6 · derivative.exercise_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2023 the first third vested and released as reported on this Form 4.

F6 · derivative.expiration_date: On February 1, 2022 the reporting person received 15,525 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 1, 2023 the first third vested and released as reported on this Form 4.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 22:46 UTC
Franchini Indrani LallEVP, CLO & Secretary
Exercise / conversionCommon Stock 5,175 $0.00 $0.00
Disclosure

SEC source: 0001735276-23-000007 · edgardoc.xml · nonDerivative · entry 1

Franchini Indrani Lall · CIK 0001708764 · EVP, CLO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.